Kala Bio (KALA) Total Current Liabilities (2016 - 2026)

Kala Bio has disclosed Total Current Liabilities across 11 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 90.4% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $1.5 million (down 90.4% YoY), while the FY2025 annual figure was $2.5 million, down 85.29% from the prior year.
• Total Current Liabilities came in at $1.5 million for Q2 2026 at Kala Bio, down from $1.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $40.2 million in Q3 2022 to a low of $1.5 million in Q2 2026.
• Average Total Current Liabilities over 5 years is $17.7 million, with a median of $16.5 million recorded in 2024.
• Year-over-year, Total Current Liabilities soared 131.7% in 2024 and tumbled 93.22% in 2026.
• Over 5 years, Total Current Liabilities stood at $25.7 million in 2022, then plunged by 67.51% to $8.3 million in 2023, then soared by 103.16% to $17.0 million in 2024, then sank by 85.29% to $2.5 million in 2025, then plunged by 38.33% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.5 million in Q2 2026, $1.6 million in Q1 2026, and $2.5 million in Q4 2025.